Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Abstracts
Book Review
Case Report
Case Series
CMAS‡ - Pancreas - EUS-FNA Cytopathology (PSC guidelines) S1:1 of 5
CMAS‡ - Pancreas - EUS-FNA Cytopathology (PSC guidelines) S1:3 of 5
CMAS‡ - Pancreas - EUS-FNA Cytopathology (PSC guidelines) S1:4 of 5
CMAS‡ - Pancreas -Sampling Techniques for Cytopathology (PSC guidelines) S1:2 of 5
CMAS‡ - Pancreas- EUS-FNA Cytopathology (PSC guidelines) S1:5 of 5
Commentary
CytoJournal Monograph Related Review Series
CytoJournal Monograph Related Review Series (CMAS), Editorial
CytoJournal Monograph Related Review Series: Editorial
Cytojournal Quiz Case
Editorial
Erratum
Letter to Editor
Letter to the Editor
Letters to Editor
Methodology
Methodology Article
Methodology Articles
Original Article
Pap Smear Collection and Preparation: Key Points
Quiz Case
Research
Research Article
Review
Review Article
Systematic Review and Meta Analysis
View Point

Getting Started

Authors need to submit their manuscripts through the online submission platform available at https://editorialassist.com/cytojournal. Articles submitted as hard copies are not accepted.

All first-time users need to register themselves. Registration is free. Once registered, authors can use their username and password to submit and keep track of their articles. In case of any problems, the author can contact the Technical Assistance at technical.team@scientificscholar.com.

Types of Manuscripts

CytoJournal  Publishes Manuscripts in the Following Categories

  • Research Article/Original article
  • Case Report
  • Case Series
  • Quiz Case
  • Review
  • Letters to the Editor
  • CytoJournal Monograph related review series
  • Editorial
  • Book Review
  • Methodology Article

General Information

CytoJournal publishes original works and findings that contribute to the advancements in the field of Molecular Cytopathology.

Author Responsibility

The journal accepts only original work that has not been published elsewhere. All authors must confirm that neither the manuscript nor any part of it was written or published or is under consideration for publication elsewhere. Publication of the content as an abstract during the proceedings of meetings is not considered prior publication and can be submitted for publication. If the study described in the manuscript had been previously presented in a meeting or published as an abstract, authors should disclose details of the same at the time of submission. The details have to be mentioned in the Acknowledgments section. Any use of previously published material protected by copyright laws must be clearly acknowledged in the manuscript. Any material publishing in a website shall be considered as prior publication and should be mentioned at the time of submission. Authors should also disclose details of related papers even those authored in a different language.

Authorship Criteria

The ICMJE recommends that authorship be based on the following 4 criteria:

  • Concept or design of the study, or acquisition of data, or analysis or interpretation of data; AND
  • Drafting the article or revising reviewing it critically for important intellectual content; AND
  • Final approval of the version to be published; AND
  • Aptitude to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved

Each contributor should have participated sufficiently in the work to take public responsibility for appropriate content of the manuscript. The order of naming the contributors should be based on the relative contribution of the individual included for authorship credit toward the study itself and the writing of the manuscript. Once the article has been submitted, the order cannot be changed without written consent from all the contributors.

The authors need to identify one author who be will corresponding with the Journal office in all matters related to the manuscript, who is termed as the Corresponding Author. It is the responsibility of the corresponding author to communicate the final manuscript including the changes as recommended by the reviewers and the editor.

Author Contribution

Each co-author’s contribution to the manuscript should meet the ICMJE authorship criteria. Contributors who do not meet all ICMJE authorship criteria should be acknowledged in the manuscript with their consent. Authors should provide a description of contributions made by each of them toward the manuscript. The description should be divided into the following categories, as deemed applicable: concept, design, definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing, and manuscript review. One or more authors should take responsibility for the integrity of the work as a whole from inception to published article and should be designated as ‘guarantor’ or ‘guarantors’.

Ethics

Studies conducted must be in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for the experiments involving humans. According to the Federal Research Misconduct Policy scientific misconduct includes:

  • Data falsification: Fabrication, deceptive and selective reporting of findings, suppression of data and/or distortion of data
  • Plagiarism: Use without permission the language, ideas, or thoughts of another and representation of them as one’s own original work

Direct copying of sentences, whether from their previously published paper or from someone else’s paper, is considered as plagiarism. Authors need to check that they have not inadvertently ‘cut and paste’ verbatim from published works. 

Scientific Misconduct

According to the Federal Research Misconduct Policy scientific misconduct includes:

  • Data falsification: Fabrication, deceptive and selective reporting of findings, suppression of data and/or distortion of data.
  • Plagiarism: Using, without permission, the language, ideas, or thoughts of another and representing them as one’s own original work. Direct copying of sentences, whether from one’s previously published paper or from someone else’s paper, is considered plagiarism. Authors need to check that they have not inadvertently “cut and paste” verbatim from published works. 

According to the World Association of Medical Editors

Plagiarism is the use of others’ published and unpublished ideas or words (or other intellectual property) without attribution or permission, and presenting them as new and original rather than derived from an existing source. The intent and effect of plagiarism are to mislead the reader as to the contributions of the plagiarizer. This applies whether the ideas or words are taken from abstracts, research grant applications, Institutional Review Board applications, or unpublished or published manuscripts in any publication format (print or electronic).

Self-plagiarism refers to the practice of an author using portions of their previous writings on the same topic in another of their publications, without specifically citing it formally in quotes. This practice is widespread and sometimes unintentional. The journal requires authors to disclose information and cite references about reused content from previously published work of their own or of others.

Incorrect authorship: Excluding authors, wrongly presenting the same material as original in more than one publication, the inclusion of authors who have not made a definite contribution to the work published; or submission of articles without the concurrence of all authors.

Misappropriation of the ideas of others: an important aspect of scholarly activity is the exchange of ideas among colleagues. Scholars can acquire novel ideas from others during the process of reviewing grant applications and manuscripts. However, improper use of such information can constitute fraud. Wholesale appropriation of such material constitutes misconduct.

Violation of generally accepted research practices: Improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results.

Material failure to comply with legislative and regulatory requirements affecting research: Violations of regulations and laws involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biologic, or chemical materials.

Any form of unethical behavior is strictly discouraged and will result in the submitting author and his group from being banned from submitting material to the journal for a time frame depending on the severity of malpractice.

Digital Image Editing Ethics

No particular feature within an image shall be introduced, moved, enhanced, obscured, or removed. Adjustments of brightness, contrast, or color balance are allowed if they are applied to the whole image and do not obscure or eliminate any information present in the original image. Adjustments such as changes to settings must be disclosed in the figure legend.

Artificial Intelligence (AI)-Assisted Technology

Authors should disclose whether they used artificial intelligence (AI) tools, such as large language models (LLMs), chatbots, or image generators, in the creation of the submitted work. If such technologies were used, then authors should describe how they were utilized in the cover letter and the relevant sections of the submitted work, where applicable. Authors are responsible for ensuring the accuracy, completeness, and originality of their work, given that these aspects are essential in authorship. They are accountable for any materials submitted that incorporate AI assistance. In addition, authors must ensure that all source materials are properly attributed, including complete citations. To access more information about Artificial Intelligence (AI)-Assisted Technology policy, visit the ICMJE website.

Conflicts of Interest/Competing Interests

All authors of must disclose any and all conflicts of interest they may have with the publication of the manuscript or any institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose any conflict of interest with products that compete with those mentioned in their manuscript.

Institutional Review Board Approval and Informed Consent

American Veterinary Medical Association (AVMA) Guidelines for the Euthanasia of Animals (2020): https://www.avma.org/resources-tools/avma-policies/avma-guidelines-euthanasia-animals

All research involving humans and animals must follow appropriate reporting guidelines and obtain ethical approval for all protocols from the local Institutional Review Board or other appropriate ethics committee before the research is conducted. Ethical approval should include the name of the review committee, the approval number, and the date, as well as informed consent forms when necessary. For example, authors are recommended to follow the World Medical Association (Declaration of Helsinki) for experiments involving humans. Authors are also recommended to follow the ARRIVE reporting guidelines when documenting animal studies. In addition, authors should consult the AVMA Guidelines for the Euthanasia of Animals (2020) as a comprehensive resource for guidance on veterinary best practices for the anesthesia and euthanasia of animals. Furthermore, authors should specify any relevant details in the methods section of their experiments, including the sex of the animals, other characteristics, and any housing and care details that might affect the experimental results.

Compliance with these rules must be stated in the text, including waiver of consent by the board, if applicable. Manuscripts that do not comply with these rules will not be accepted for publication.

Protection of Patients’ Right to Privacy

For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 16 years of age) and a statement to this effect should appear in the manuscript.

Identifying information, including patients’ names, initials, or hospital numbers, should not be published in written descriptions, CT scans, photographs, sonograms or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable should be shown the manuscript to be published.

Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.

Reporting Guidelines

Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT Statement.
Reporting Guidelines for Specific manuscript types are given below. A statement of compliance with the appropriate guideline must be included on the title page of the manuscript.

Guideline Type of Study Source
STROBE Observational studies including cohort, case-control, and cross-sectional studies https://www.strobe-statement.org/index.php?id=available-checklists
CONSORT Randomized controlled trials http://www.consort-statement.org
SQUIRE Quality improvement projects http://squire-statement.org/index.cfm?fuseaction=Page.ViewPage&PageID=471
PRISMA Systematic reviews and meta-analyses http://prisma-statement.org/PRISMAStatement/Checklist.aspx
STARD Studies of diagnostic accuracy https://pubs.rsna.org/doi/full/10.1148/radiol.2015151516
CARE Case Reports https://www.care-statement.org/checklist
AGREE Clinical Practice Guidelines https://www.agreetrust.org/wp-content/uploads/2016/02/AGREE-Reporting-Checklist-2016.pdf
SPIRIT Protocol Reporting https://spirit-statement.org/title/
COREQ Qualitative Studies https://cdn.elsevier.com/promis_misc/ISSM_COREQ_Checklist.pdf
The reporting guidelines for other types of studies can be found at https://www.equator-network.org/reporting-guidelines/.

 

The Editorial Process

CytoJournal has a highly rigorous and unbiased double anonymized peer-review process that makes sure that manuscripts are scientifically accurate, relevant, novel, and meaningful.

Decisions on accepting manuscripts for publication are solely based on the peer-review process, and the Editor’s discretion and the decision are final. The manuscript is sent for peer review to at least two external reviewers, and if required, it is sent to a third reviewer to act as a tie-breaker. A completed review by two reviewers recommending the acceptance of the manuscript for publication is mandatory.

In the double anonymized review process, the reviewers and authors are unaware of each other’s identity. The comments and suggestions (acceptance/rejection/amendments to the manuscript) received from reviewers are conveyed to the author anonymously. The author is requested to provide a point-by-point response to reviewers’ comments and submit a revised manuscript version. This process is repeated until reviewers and editors are satisfied with the manuscript.

Manuscripts accepted for publication are copy-edited for grammar, punctuation, print style, and format. Galley proofs are sent to the author. The author is expected to return the corrected proofs strictly within three days. It may not be possible to incorporate corrections received after that period. All the communication between the Journal and the author is completely online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online immediately on final acceptance.

Manuscripts that do not confirm to the Author Guidelines or exceed the Maximums set for Articles will be returned to the authors for technical modification without review. Authors need to resubmit the manuscript after complying with the requirements.

In-house submissions
In-house submissions that contain the work of any editorial board member are not allowed to be reviewed by that editorial board member, and an independent editor makes all decisions regarding this manuscript. In addition, these manuscripts are reviewed by two external reviewers. This is also disclosed in the published manuscript under the section of Conflict of Interest.

Data Sharing Policy

NIH funded researchers, please follow the NIH guidelines on Data sharing as given at: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-013.html

Preparation of the Manuscript

Upload Cover Letter/Page and Manuscript file. Manuscript should include graphs, tables, references, and acknowledgments. Acceptable file formats are MS Word “doc” or “docx.”

Language and Writing Style

The manuscript should be written in American English. The author should write the full term for each abbreviation at its first use in the title, abstract, keywords and text separately unless the abbreviation is a standard unit of measure. Use of acronyms and abbreviations must be kept to a minimum. When used, they are defined at first mention, followed by the acronym or abbreviation in parentheses. If a brand name is cited, supply the manufacturer’s name and address (city, state, and country). Manuscripts are expected to meet the style guidelines of the CytoJournal. Authors are requested to check the manuscript for spelling, grammar, and punctuation errors before submission.

Organization of Sections in an Article

Cover Page

Cover page includes (a) complete manuscript title; (b) List of all authors’ full names, highest academic degrees, professional titles, affiliations, and locations of affiliations; (c) Details of the corresponding author – name, address, and e-mail address and (d) sources of support that require acknowledgment, and a running title of not more than 45 characters (including spaces).

Abstract

An abstract is required for all categories of manuscripts. The abstract should not exceed 500 words. The content should not have any subheadings.

For an Research article, the abstract should be divided into four sections: Objective, Methods, Results, and Conclusions not exceeding 500 words.

No abstract should contain any figures, tables, or references, trade names, or manufacturers names.

Keywords

Provide up to five keywords at the end of the abstract for all types of articles except for Letters to the Editor and Replies.

Introduction

All articles need an Introduction that describes the objective of the investigation of not more than 500 words. The author should clearly state the specific goal or purpose of the article, and indicate why it is worthy of attention. In the Introduction, describe the hypothesis to be tested, the dilemma to be resolved, or the deficiency to be remedied.

Materials and Methods or Subject Profile

The research plan, the materials (or subjects), and the methods used should be described. An explanation on how the disease was confirmed and the controls used must be included, as well as the details of the data obtained and how it was analyzed. Methods must include the following aspects:

When a surgical device is mentioned in the manuscript for the first time, its manufactures complete detail should be mentioned such as the BRAND name of the device/medication followed by name of manufacturer, city, and state. For example IVC filter (C.R. Bard, Inc. Murray Hill, New Jersey, USA). Please mention the name of the Ultrasound machine, its manufacturer, and country of origin. In addition please mention the type of the transducer and its frequency used for the study. This should be mentioned in the methods or the section where you describe how the ultrasound was performed. For Example GE, Logiq E9, Milwaukee, USA

Ethics: All research involving humans and animals must obtain ethical approval from the local Institutional Review Board or other appropriate ethics committee before it is conducted and include a statement on ethics committee permission and ethical practices in the ‘Materials and Methods’ section of all original research manuscripts. For more information, visit the Institutional Review Board Approval and Informed Consent section.

Patient consent: Patient anonymity must be maintained in all submissions. If there is any possibility that the patient can be identified in a figure, written consent must be obtained from the patient or parent/guardian by the author, and a line stating that this has been received included in the article.

Study Design

Selection and Description of Participants: Describe your selection of the observational or experimental participants (patients or laboratory animals, including controls) clearly, including eligibility and exclusion criteria and a description of the source population.

Technical information: Identify the methods, apparatus (give the manufacturer’s name and address in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods (see below); provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration.

Reports of randomized clinical trials should present information on all major study elements, including the protocol number and date, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT Statement.

Statistics

Wherever possible quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Authors should report losses to observation (such as dropouts from a clinical trial). When data are summarized in the Result section, specify the statistical methods used to analyze them. Avoid non-technical uses of technical terms in statistics, such as ‘random’ (which implies a randomizing device), ‘normal’, ‘significant’, ‘correlations’, and ‘sample’. Define statistical terms, abbreviations, and most symbols. Specify the software used for analysis. We recommend that authors refer to the relevant regulations of ICMJE: ith access to the original data to judge its appropriateness for the study and verify tDescribe statistical methods with sufficient detail to enable a knowledgeable reader whe reported results. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (e.g., confidence intervals). Avoid relying solely on statistical hypothesis testing, such as P values, which fail to convey important information about effect size and precision of estimates.

Results

All results should be in a clear, logical sequence and should adhere to the specific objective of the paper. Data presented in tables should not be duplicated in the text. However, important trends and points observed in the study will need to be described. While summarizing data, give numeric results not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated; also specify the statistical methods used to analyze them. Restrict tables and figures to those needed to explain the argument of the paper and to assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. Where scientifically appropriate, analyses of the data by variables such as age and sex should be included.

Discussion

The article submitted should explain clearly the outcome of the research considering the goals and results obtained. Any limitations on the materials or subjects and methods must be included. The results differing from those obtained by previous investigators need to be presented with adequate comparisons and explanations. Include key findings (primary outcome measures, secondary outcome measures and results as they relate to a prior hypothesis); Strengths and limitations of the study (study question, study design, data collection, analysis and interpretation); Interpretation and implications in the context of the totality of evidence should be described. Include what this study adds to the available evidence, effects on patient care and health policy, etc.

Do not repeat the data or other material mentioned in the Introduction or the Results section. In particular, contributors should avoid making statements on economic benefits and costs unless their manuscript includes economic data and analyses. Avoid claiming priority and alluding to work that has not been completed.

References

References are to be numbered sequentially in the order in which they appear in the manuscript. Reference numbers are typed as superscripts, enclosed by square brackets.

Example: …… with no evidence of intratubular testicular neoplasia.[1]

Unpublished data or articles submitted for publication are not to be cited in the reference list. They are cited within parenthesis in the text. (Example: Aaron J, unpublished data). Papers presented at meetings are not cited in the reference list. They are cited within parenthesis in the text. (Example: Aaron J et al., presented at the 2009 annual meeting of the Society).

References follow the ICMJE guidelines. Author’s surname is followed by the author’s initials in capitals without spaces or full stops. All references show page numbers in the format (121-26). Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names, or access the list from here.

Sample references are given below:

Articles in Journals
1. Olson MC, Posniak HV, Fisher SG, Flisak ME, Salomon CG, Flanigan RC, et al. Directed and random biopsies of the prostate: indications based on combined results of transrectal sonography and prostate-specific antigen density determinations. Am J Roentgenol 1994;163:1407–11.

List the first six contributors followed by et al in all references.

2. Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002;935:40-6.

Issue with supplement
3. Payne DK, Sullivan MD, Massie MJ. Women’s psychological reactions to breast cancer. Semin Oncol 1996;23(1, Suppl 2):89-97.

Volume with supplement
4. Shen HM, Zhang QF. Risk assessment of nickel carcinogenicity and occupational lung cancer. Environ Health Perspect 1994;102 Suppl 1:275-82.

Books and Other Monographs

Personal Author(s):

5. Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers; 1996.

Editor(s), compiler(s) as author:

6. Norman IJ, Redfern SJ, editors. Mental health care for elderly people. New York: Churchill Livingstone; 1996.

Chapter in A Book
7. Turgut AT, Dogra VS. Prostate carcinoma: Evaluation using transrectal sonography. In: Hayat MA, ed. Methods of cancer diagnosis, therapy, and prognosis. 1st ed. New York, NA: Elsevier; 2008. p. 499-520.

Electronic Sources as Reference

Refer APA’s Quick guide on reference for electronic references.

Monograph on the Internet format: Foley KM, Gelband H, editors. Improving palliative care for cancer [monograph on the Internet]. Washington: National Academy Press; 2001 [cited 2002 Jul 9].

Refer Homepage/Web site and Part of a homepage/Web site formats in the hyperlink provided

Tables

Tables must be significant and provide a good summary of the study. Tables should be self-explanatory and not duplicate of the data given in the text or figures. Each table must have a descriptive title, and each column a heading. Tables must contain a minimum of four lines and two columns of data and not exceeding 10 columns and 25 rows. Tables are numbered in the order in which they are cited in the text. Abbreviations used in the tables are defined below each table. All arithmetic calculations (percentages, totals, differences) must be double-checked for accuracy, and data must agree with the data given in the text.

Graphs

Graphs need to be exported as JPEG or TIF images and submitted as figures. Graphs and line drawings need to be a minimum of 1000 dpi. Graphs should include clearly labeled error bars described in the figure legend. Authors must state whether a number that follows the ± sign is a standard error of the mean (SEM) or a standard deviation (SD). The number of independent data points (N) represented in a graph must be indicated in the legend. Numerical axes on graphs should go to 0, except for log axes.

Figure/Image Legends

All figure parts relating to one image should have the same figure number. The figure legendsshould strictly follow the format as the following:
Figure 1: Age and gender of the patient followed by presenting symptoms and subsequent diagnosis. Imaging modality used, organ/section imaged, view, and abnormality seen in the image. It is important to add arrows pointing to the abnormality seen in the image.
Example: Figure 1: 42-year-old woman with Behçet disease who presented with dyspnea. (a) Contrast-enhanced CT image shows the increased diameter of both middle and lower lobe pulmonary arteries (arrows) on the right; the aneurysms are partially thrombosed. (b) CT image with lung window shows well-defined lung parenchymal nodules (arrow) corresponding to the aneurysms.

Written permission to reprint in print and electronic media, including online use, must be obtained for all previously published illustrations, and an appropriate credit line to be given in the legends.

Figures/Images

All images should be uploaded in JPEG or TIFF, format. The file size should be within 12 MB. Figures should be numbered consecutively according to the order in which they have been first cited in the text. Labels, numbers, and symbols should be clear and of uniform size. The lettering for figures should be legible enough even after reducing to fit the width of a printed column. Symbols, arrows, or letters used in photomicrographs should contrast with the background and should be marked neatly with transfer type or by tissue overlay and not by pen. Titles and detailed explanations belong in the legends for figures not on the figure/image themselves. The photographs and figures should be trimmed to remove all the unwanted areas and the patient’s name and medical record number. If photographs of individuals are used, their pictures must be accompanied by written permission to use the photograph and eyes must be covered. If a figure has been published elsewhere, the original source must be acknowledged and written permission from the copyright holder submitted to reproduce the material. A credit line should appear in the legend for such figures. Electronic manipulation of images that materially alters the medical information must be identified and the nature of the alterations described. Symbols used must be uniform in size & style and large enough to withstand reduction. Line drawings and graphs should be in black on a white background, using the same size type as the text. 0.5 mm hairline rules must be avoided. Authors’ names and affiliations must not appear anywhere on the images.

Image Size

Black & white images: should be in JPEG or TIFF format of Grayscale mode, and 300 DPI resolution. The height and width of an image should be at least 6 x 5 inches.

Color images: should be in 300 DPI resolution without any layered files and alpha channels. Color profile if used should be in CMYK (No Indexed Color, Lab, or RGB profiles) only.

Line art: should be in 1200 DPI resolution of Grayscale or JPEG format. Layered files and alpha channels should not be used. Color profile if used should be in CMYK (No Indexed Color, Lab, or RGB profiles) only. The Journal reserves the right to crop, rotate, reduce, or enlarge the photographs to an acceptable size.

Video Clips

The journal encourages authors to submit video clips, cine clips, or real-time images (preferably in ‘mp4’). The maximum size of each multimedia file should not exceed 400 MB. In addition to the video content, authors must provide a still image from each video file. Provide only TIFF or JPEG files.

Submission of the Manuscript

Online Manuscript Submission

All manuscripts must be submitted online at CytoJournal. You will see step-by-step instructions when you are submitting your manuscript. You will need to submit the following documents as separate files.

  1. Cover Page:
    Cover page includes (a) complete manuscript title; (b) List of all authors’ full names, highest academic degrees, professional titles, affiliations, and locations of affiliations; (c) Details of the corresponding author – name, address, telephone number, and e-mail address and (d) sources of support that require acknowledgment, and a running title of not more than 45 characters (including spaces).
  2. Manuscript:
    This document should include the title, abstract, keywords, manuscript body, and references. This must be in document format. Acknowledgment Section should be included at the end of the main manuscript. Acknowledgment should not contain the name of the city or the institution.
  3. Figures:
    Figures must be submitted in .tiff or jpeg format. Color images should be of good quality. Each image should be less than 1 MB in size. Size of the image can be reduced by decreasing the actual height and width of the images (1240 x 800 pixels or 5-6 inches).

    Figure legends should be uploaded as a document format.

  4. Graphs:
    Do not embed them in the main manuscript. They should be uploaded separately at the time of uploading the figures in the “jpeg” or “tiff” format.
  5. Tables:
    Tables should be included in the main manuscript file after the references.
  6. Copyright and disclosure forms are available for download from the author’s panel and should be uploaded as PDF file.
  7. Corresponding Author’s passport size photo is required and can be uploaded at the time of uploading figures etc.
  8. Instruction on supplemental digital multimedia/video content: In addition to the video content, authors must provide a still image from each video file. Supply TIFF or JPEG files. These are also uploaded at the time of figure upload.

Specific Details for Each Manuscript Type

Research Article

A research article is a research paper based on unique findings and techniques and provides new information on the topic.

Appropriate statistical data are necessary for findings to be conclusive. The Methods section should contain the criteria for selecting human participants and laboratory animals involved in the trials and provide evidence of approval from relevant ethics organizations. When human subjects are involved, the methods followed and the extent to which they were in accordance with ethical standards and the Human Rights guidelines need to be indicated.

Research articles should include the following sections: 

  • Abstract: Objectives, Methods and Materials, Results, and Conclusion in brief, not exceeding 500 words.
  • Keywords: Up to five keywords.
  • Main text: Introduction, Methods, Results, Discussion, and Conclusion, collectively not exceeding 5,000 words. 
  • References: A maximum of 90 references.
  • Figures/Tables: No limit to the number of figures and tables, but please keep them to a minimum. See details in Tables/Graphs/Figure/Image and Video.

Case Report

Case report should be new, unique, and clinically significant. The cases must have a diagnostic impact or describe a therapeutic challenge and provide a learning opportunity for readers. A cluster of cases can be submitted under the category of case reports. A cluster will depict one disease process with different presentations.

Case reports should include the following sections: 

  • Unstructured Abstract: Up to a maximum of 500 words.
  • Keywords: Up to five keywords.
  • Main text: Introduction, Case report, Discussion, and Conclusion, collectively not exceeding 1,500 words.
  • References: A maximum of 10 references.
  • Figures/Tables: 6 figures and one table. 

Case Series

Case series are a type of CytoJournal publication that tracks subjects with comparable cytopathological findings and overlapping diagnostic challenges with important learning insights.

Case series should include the following sections: 

  • Abstract: Up to a maximum of 500 words.
  • Keywords: Up to five keywords.
  • Main text: Introduction, Cases, and Discussion ending with Summary. collectively not exceeding 1,500 words.
  • References: A maximum of 10 references.
  • Figures/Tables: Reasonable number of good quality figures and tables. 

Quiz Case

As a Quiz case, authors shall present a clinical case to communicate teaching point(s) by in quiz format to generate an inquisitive interest for educational progress.

To view all quiz case articles: https://cytojournal.com/category/quiz-case/.

Template for Quiz Case – Download here.

 

Review Article

A review article is a balanced, in-depth scholarly study of the latest trends or the present status of a specific, timely topic. It is not an original article, which means that no new data or personal experiences are presented. Instead, it analyzes advances in the field based on a literature review. 

Review articles should include the following sections: 

  • Abstract: Concise abstract limited to 200–350 words. 
  • Keywords: Up to five keywords.
  • Main text: Detailed description of each disease process with appropriate images and a valid conclusion, up to a maximum of 4,000 words. 
  • References: A maximum of 90 references.
  • Figures/Tables: No limit to the number of figures and tables, but please keep them to a minimum. See details in Tables/Graphs/Figure/Image and Video.

Letter to the Editor

Letter to the Editor should be brief and succinct based on constructive criticism of articles published in the CytoJournal within the previous two months. The letter and reply should be solely based on the data published in the article. Letters should not duplicate prior published material or be under consideration for publication elsewhere. The Editor-in-Chief will use his discretion to publish or reject the letter. These letters and replies do not undergo peer review. Submitted letters are subject to editing for content and style. 

Letter to the Editor should include the following sections: 

  • Main text: Not exceeding 1,000 words. 
  • References: A maximum of 4 references.
  • Figures/Tables: 2 figures or a total of 4 images; no tables are allowed. 

CytoJournal Monograph related review series

Comprehensive, authoritative descriptions of any subject within the scope of CytoJournal shall be submitted under CytoJournal Monograph related review series. These reviews are usually written by opinion leaders who were invited by the CytoJournal Monograph & Atlas (CMAS) committee and peer-reviewed under leadership of CytoJournal Monograph & Atlas (CMAS) Editorial Board. The peer-review process for these series is not double blind.

Editorials

Short, focused, and opinionated articles on any subject within the scope of CytoJournal shall be submitted as Editorials. These articles are usually related to a contemporary issues, such as recent research findings, and are often written by opinion leaders invited by the Editorial Board.

Abstracts are not required for Editorials. Typically, this type of manuscript does not exceed 1,000 words. At most, one table or figure is allowed. The number of references should not exceed 10.

Book Review

Book reviews are short summaries of the strengths and weaknesses of a book. The review should evaluate the overall significance of the book to the intended audience. They are typically short pieces of work, with around 500–750 words in length. They may sometimes be shorter or longer but will rarely exceed 1,000 words. 

Methodology Articles

Methodology articles present a new experimental method, test, or procedure. The method described should be either completely new or offer a better version of an existing method. The article must describe a demonstrable advance on what is currently available.
Methodology articles need a short, unstructured, single-paragraph summary, no longer than 200 words, highlighting the major points without including any references. Three to ten keywords representing the main content of the article should be given.
 

Publication/Processing Fee

Article Processing Charge

The CytoJournal charges $2500 for all the accepted manuscripts.

Copyright and Open Access Statement

Authors Retain Copyright

All of the content published in the CytoJournal is protected under the International copyright law, defined by Creative Commons and International Council of Medical Journal Editors (ICMJE). The author of an article retains the academic copyright of the content and can self-archive the article. The journal retains the commercial rights of the published content and publisher executes the commercial rights on behalf of the journal. The journal also grants to all readers and users a free, irrevocable, global, perpetual right of access to, and a license to copy, use, distribute and display the content publicly and to make and distribute derivative works in any digital medium for any reasonable and non-commercial purpose, subject to proper attribution of authorship and ownership of the copyrights under the Creative Commons Attribution-Noncommercial-Share Alike 4.0 International Public License.

Open Access Publication and Creative Commons Licensing

CytoJournal is an open-access journal, and manuscripts published are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License (CC-BY-NC-SA 4.0), which allows others to remix, transform, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Compliance with Funder-Mandated Open Access Policies
An author whose work is funded by an organization that mandates the use of the Creative Commons Attribution-Non-Commercial-Share Alike 4.0 License is able to meet that requirement through the available open-access license for approved funders.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.  For any Questions or Difficulties please contact us technical.team@scientificscholar.com.